Anebulo Pharmaceuticals, Inc

/Anebulo Pharmaceuticals, Inc

IPO

Anebulo Pharmaceuticals, Inc

Biotechnology

We are a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Our lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration.

Symbol

ANEB

Price Range
$6.00 - $8.00

Final Shares
3,000,000

Anticipated Date
May 7, 2021

Underwriters
THE BENCHMARK COMPANY, LLC

This offering is no longer available

To view the prospectus for Anebulo Pharmaceuticals, Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange